Healthy Lifestyle Program for Fatty Liver Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a lifestyle program called the Healthy Liver/Hígado Sano can aid Hispanic/Latino individuals with non-alcoholic fatty liver disease in losing weight and improving liver function. Participants will either follow this new program or continue with their usual care to determine which is more effective. Eligible participants should be Hispanic/Latino, diagnosed with this liver condition, and have a family member who can attend all sessions. They must also have internet access and be able to speak English or Spanish. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance health outcomes for the Hispanic/Latino community.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Healthy Liver/Hígado Sano program is safe for improving liver health?
A previous study showed that programs like Healthy Liver/Hígado Sano are safe for participants. These programs help people improve their diet and increase physical activity, which most handle well. No reports of serious side effects have emerged from joining these programs. Participants might experience temporary soreness or tiredness from increased activity, but these effects are usually mild and manageable. Overall, the Healthy Liver/Hígado Sano program is considered safe for those aiming to improve liver health and lose weight.12345
Why are researchers excited about this trial?
Researchers are excited about the Healthy Liver/Hígado Sano program because it offers a fresh approach to managing fatty liver disease through lifestyle modifications rather than medication or surgery. Unlike standard treatments, which often involve drugs like vitamin E or pioglitazone, this program emphasizes a holistic lifestyle change, focusing on diet, exercise, and behavioral support to improve liver health. By empowering patients to make sustainable changes, this program could potentially reduce liver fat and inflammation naturally, providing a non-invasive alternative that aligns with overall wellness goals.
What evidence suggests that the Healthy Liver/Hígado Sano program might be an effective treatment for fatty liver disease?
Research has shown that lifestyle changes can improve liver health in people with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD). In this trial, participants will either follow the Healthy Liver/Hígado Sano program, a lifestyle change plan designed for Hispanic/Latino patients, or receive usual care. Early studies suggest that programs like the Healthy Liver/Hígado Sano program can help reduce liver fat by promoting healthy eating and exercise. For instance, following a Mediterranean diet, which includes healthy fats, has decreased liver fat. These findings offer hope that the Healthy Liver/Hígado Sano program may help patients lose weight and improve their liver health.678910
Who Is on the Research Team?
Natalia Heredia
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD). Participants should be interested in weight loss and improving liver health. Specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the Healthy Liver/Hígado Sano program, a behavioral lifestyle intervention aimed at improving liver health and promoting weight loss
Follow-up
Participants are monitored for changes in physical activity and diet, as well as overall satisfaction with the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Healthy Liver/Hígado Sano program
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator